Abstract:Induced pluripotent stem cells (iPSC) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques, which may open up new possibilities for regenerative medicine to treat diseases in the future. Biotechnological, chemical, and physical modulation techniques are different reprogramming cell technologies to obtain iPSC and present their respective strengths in iPSC reprogramming‐based regenerative therapies, such as hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. Induced pluripotent stem cells (iPSCs) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques. With their unlimited proliferative capacity and multifaceted differentiation potential and circumventing the ethical problems encountered in the application of embryonic stem cells (ESC), iPSCs have a broad application in the fields of cell therapy, drug screening, and disease models and may open up new possibilities for regenerative medicine to treat diseases in the future. In this review, we begin with different reprogramming cell technologies to obtain iPSCs, including biotechnological, chemical, and physical modulation techniques, and present their respective strengths, and limitations, as well as the recent progress of research. Secondly, we review recent research advances in iPSC reprogramming‐based regenerative therapies. iPSCs are now widely used to study various clinical diseases of hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. This review focuses on the translational clinical research around iPSCs as well as their potential for growth in the medical field. Finally, we summarize the overall review and look at the potential future of iPSCs in the field of cell therapy as well as tissue regeneration engineering and possible problems. We believe that the advancing iPSC research will help drive long‐awaited breakthroughs in cellular therapy.

Generation of Patient-Specific Pluripotent Stem Cells and Directed Differentiation of Embryonic Stem Cells for Regenerative Medicine

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Direct generation of pluripotent stem cells from differentiated somatic cells]

Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications.

Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery Behind Reprogramming

Derivation and Application of Pluripotent Stem Cells for Regenerative Medicine

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Differentiation of pluripotent stem cells for regenerative medicine

Strategies and New Developments in the Generation of Pluripotent Stem Cells.

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

Induced Pluripotent Stem Cell Technology in Regenerative Medicine and Biology

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Progress in the Reprogramming of Somatic Cells

From One-Cell to Tissue: Reprogramming, Cell Differentiation and Tissue Engineering

Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases

Challenges to the Clinical Application of Pluripotent Stem Cells: Towards Genomic and Functional Stability.

Advances in generation of disease-specific induced pluripotent stem (iPS) cells

Directed Neuronal Differentiation of Mouse Embryonic and Induced Pluripotent Stem Cells and Their Gene Expression Profiles

Prospects of Induced Pluripotent Stem Cell Technology in Regenerative Medicine.

Reprogramming stem cells in regenerative medicine

Generation and Application of Human Ips Cells